UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: August 19, 2021
Accession Number:
Submission Type:
CIK: 0001106838
Company Name: Sonnet BioTherapeutics Holdings, Inc.
File Number: 333-258092